Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter

Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as against Rs 19.80 crore during the previous quarter ended September 2023. Sales rose 12.04% to Rs 222.70 crore in the quarter ended September 2024 as against Rs 198.76 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	222.70	198.76	12
OPM %	13.62	11.73	-
PBDT	34.53	27.86	24
PBT	25.90	20.02	29
NP	27.24	19.80	38